Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

This trial aimed to evaluate the efficacy of sirolimus in addition to cyclosporine (CSP) and mycophenolate mofetil (MMF) for graft-versus-host disease (GVHD) prophylaxis after nonmyeloablative conditioning for HLA class I or II mismatched hematopoietic cell transplantation (HCT). Eligible patients h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Kornblit, Brian, Storer, Barry E., Andersen, Niels S., Maris, Michael B., Chauncey, Thomas R., Petersdorf, Effie W., Woolfrey, Ann E., Flowers, Mary E. D., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515688/
https://ncbi.nlm.nih.gov/pubmed/32603426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005338
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars